These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7042373)

  • 1. Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.
    van der Veur E; ten Berge BS; Donker AJ; May JF; Wesseling H
    Eur J Clin Pharmacol; 1982; 21(6):457-60. PubMed ID: 7042373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
    Fea F; Salvioli G; Planca E; Pelliccioli I; Foti F; Colombo G
    Boll Soc Ital Cardiol; 1981; 26(12):2173-82. PubMed ID: 7185386
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A; Allonen H; Kleimola T
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
    Weber MA; Drayer JI; Kaufman CA
    J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol in the treatment of essential hypertension.
    JAMA; 1977 May; 237(21):2303-10. PubMed ID: 323525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative hemodynamic effects of labetalol and hydralazine in the treatment of postoperative hypertension.
    Dimich I; Lingham R; Gabrielson G; Singh PP; Kaplan JA
    J Clin Anesth; 1989; 1(3):201-6. PubMed ID: 2627388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Gaynor MF; Wright GC; Vondracek S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous labetalol in severe hypertension.
    Dal Palu C; Pessina AC; Semplicini A; Hlede M; Morandin F; Palatini P; Sperti G; Rossi GP
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):97S-99S. PubMed ID: 7093106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.
    Thibonnier M; Lardoux MD; Corvol P
    Br J Clin Pharmacol; 1980 Jun; 9(6):561-7. PubMed ID: 6992823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with asthma and propranolol sensitivity.
    George RB; Light RW; Hudson LD; Conrad SA; Chetty K; Manocha K; Burford JG
    Chest; 1985 Dec; 88(6):815-8. PubMed ID: 3905285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol in the treatment of essential hypertension: a single-blind dose ranging study.
    Dux S; Grosskopf I; Boner G; Rosenfeld JB
    J Clin Pharmacol; 1986; 26(5):346-50. PubMed ID: 3700690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine.
    McKay C; Hall AB; Cortes J
    J Neurosci Nurs; 2015 Dec; 47(6):327-32. PubMed ID: 26528950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and combined therapy for systemic hypertension with propranolol, hydralazine and hydrochlorothiazide: hemodynamic and neuroendocrine mechanisms of action.
    Mulvihill-Wilson J; Gaffney FA; Neal WW; Graham RM; Pettinger WA; Blomqvist CG
    Am J Cardiol; 1985 Aug; 56(4):315-20. PubMed ID: 4025172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.
    van der Veur E; ten Berge BS; Donker AJ; May JF; Schuurman FH; Wesseling H
    Eur J Clin Pharmacol; 1985; 28(5):507-11. PubMed ID: 3899671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.